Modulation of Immunity by Antiangiogenic Molecules in Cancer
In the last decades a new class of therapeutic drugs have been developed that block tumor angiogenesis. These antiangiogenic molecules, which target VEGF or VEGFR, PDGFR, and c-kit, can act not only on endothelial cells but also on immune cells. Some antiangiogenic molecules inhibit the development...
Saved in:
Main Authors: | Magali Terme, Orianne Colussi, Elie Marcheteau, Corinne Tanchot, Eric Tartour, Julien Taieb |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2012/492920 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disrupted Balance of Angiogenic and Antiangiogenic Signalings in Preeclampsia
by: Mitsuko Furuya, et al.
Published: (2011-01-01) -
Proapoptotic and Antiangiogenic Activities of Arctium Lappa L. on Breast Cancer Cell Lines
by: Mohamad Taleb Agha, et al.
Published: (2020-01-01) -
Prospects of Antiangiogenic Therapy for Portal Hypertension in Liver Cirrhosis
by: D. V. Garbuzenko
Published: (2018-11-01) -
Modulation of Tumor Immunity by Soluble and Membrane-Bound Molecules at the Immunological Synapse
by: Pablo A. González, et al.
Published: (2013-01-01) -
Neoadjuvant chemotherapy combined with antiangiogenic therapy and immune checkpoint inhibitors for the treatment of locally advanced gastric cancer: a real - world retrospective cohort study
by: Zhouwei Zhan, et al.
Published: (2025-02-01)